Anti-LRP4 myasthenia gravis (MG): management
Evidence-based neurology checklist on anti-lrp4 myasthenia gravis (mg): management: Chest CT Electromyogram (EMG): this is usually normal CT chest: this shows thymus hyperplasia in about a third of cases Treatment Acronym
Chest CT
- Electromyogram (EMG): this is usually normal
- CT chest: this shows thymus hyperplasia in about a third of cases
Treatment
Acronym
References
- Nikolic AV, Bojic SD, Rakocevic Stojanovic VM, Basta IZ, Lavrnic DV. Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis. Eur J Neurol 2016; 23:1635-1641.
- Li Y, Zhang Y, Cai G, He D, Dai Q, Xu Z, Chu L. Anti-LRP4 autoantibodies in Chinese patients with myasthenia gravis. Muscle Nerve 2017; 56:938-942.
- Zisimopoulou P, Evangelakou P, Tzartos J, et al. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun 2014; 52:139-145.
